Psychiatry and Neurology, Neurology · Germantown, TN
NPI
1730132788
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7645 Wolf River Cir, Suite 100
Germantown, TN, 38138
Phone (901) 405-0275
Groups this clinician bills Medicare through
Medicare paid, 2024
$678K
20,673 services
Medicare patients, 2024
1,260
Average age 73
Drug cost, 2024
$8.1M
10,008 prescriptions
Company payments, 2025
$34K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shiva S Natarajan was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,100 times for 30 patients. In total Shiva S Natarajan billed 20,673 services in 55 codes, and Medicare paid $678K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,100 | 30 | $4.48 | $27K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,870 | 19 | $0.11 | $410 |
| J0586 Injection, abobotulinumtoxina, 5 units | Office | 3,500 | 19 | $6.45 | $23K |
| 99214 Office E&M - Established | Office | 505 | 402 | $76.13 | $38K |
| 99223 Hospital E&M - Initial | Facility | 417 | 389 | $117.02 | $49K |
| 99232 Hospital E&M - Subsequent | Facility | 336 | 174 | $54.30 | $18K |
| 99204 Office E&M - New | Office | 248 | 248 | $106.16 | $26K |
| 99215 Office E&M - Established | Office | 216 | 189 | $112.73 | $24K |
| 95886 Electrical Nerve Conductivity | Office | 206 | 92 | $63.41 | $13K |
| 96139 Behavioral Health Services | Office | 172 | 52 | $21.99 | $3,783 |
| 95812 Neurologic | Office | 117 | 117 | $214.92 | $25K |
| 95957 Neurologic | Office | 114 | 114 | $191.61 | $22K |
| 95816 Neurologic | Facility | 102 | 96 | $38.28 | $3,904 |
| 96133 Behavioral Health Services | Office | 60 | 30 | $67.21 | $4,033 |
| 96138 Behavioral Health Services | Office | 52 | 52 | $20.25 | $1,053 |
By year: 2022 $780K for 35,702 services; 2023 $757K for 38,657 services; 2024 $678K for 20,673 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shiva S Natarajan prescribed most often to Medicare patients was Levetiracetam, with 776 prescriptions and refills. In total Shiva S Natarajan wrote 10,008 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 776 | 1,215 | 180 | $24K |
| Donepezil Hcl Generic | 504 | 894 | 158 | $7,203 |
| Lamotrigine Generic | 415 | 634 | 76 | $7,651 |
| Gabapentin Generic | 407 | 587 | 121 | $6,024 |
| Duloxetine Hcl Generic | 393 | 624 | 122 | $7,362 |
| Xcopri Cenobamate | 367 | 378 | 41 | $475K |
| Primidone Generic | 365 | 594 | 98 | $6,842 |
| Pregabalin Generic | 354 | 437 | 96 | $5,035 |
| Tizanidine Hcl Generic | 320 | 416 | 88 | $1,968 |
| Memantine Hcl Generic | 303 | 439 | 92 | $6,299 |
| Lacosamide Generic | 292 | 338 | 50 | $33K |
| Topiramate Generic | 258 | 413 | 62 | $2,185 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 230 | 350 | 53 | $14K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 194 | 347 | 60 | $3,530 |
| Clonazepam Generic | 169 | 173 | 29 | $1,891 |
Brand drugs: 1,837 claims; generic drugs: 8,100 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shiva S Natarajan $34K ($34K in general payments such as food, travel and fees) from 28 companies. The largest payer was Pfizer Inc. with $22K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 55 | $22K |
| SK Life Science, Inc. | 21 | $8,381 |
| UCB, Inc. UCB.BR | 22 | $534 |
| Novartis Pharmaceuticals Corporation NVS | 29 | $455 |
| Celgene Corporation BMY | 16 | $238 |
| Argenx US, Inc. ARGX | 9 | $210 |
| Abbvie Inc. ABBV | 20 | $182 |
| Harmony Biosciences LLC HRMY | 5 | $178 |
| TG Therapeutics, Inc. TGTX | 6 | $163 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.